News
Diageo's share price has dropped 15.3% in the year to date. Could it be about to become one of the FTSE 100's best recovery ...
Eli Lilly is proving that being second but better can also pay. Zepbound, the American firm’s weight-loss jab, was approved ...
10h
HealthShots on MSNSophia Umansky highlights Mounjaro side effects, fears ‘I’m gonna be bald’Sophia Umansky, daughter of Real Housewives of Beverly Hills star Kyle Richards, opened up about a side effect she never ...
Novo Nordisk, which also makes Wegovy, fell victim to 'compounding' - a practice in the US that allows pharmacies to produce ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
As we learn more about GLP-1 drugs like Wegovy and Zepbound, early research suggests that they may be able to improve COPD ...
We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra. In this article, we will summarize the ...
U.S. District Judge Mark Pittman in Texas issued the sealed order on Wednesday in response to a lawsuit filed in October by a ...
A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...
WW International shares plummeted Wednesday after the company, better known as WeightWatchers, filed for Chapter 11 ...
GLP-1 receptor agonists remain blockbuster drugs for weight management for people with overweight or obesity. Increasingly, ...
Eli Lilly won’t lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results